{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T07:42:50Z","timestamp":1790062970816,"version":"4.0.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1111\/igc.0b013e3181ef10aa","type":"journal-article","created":{"date-parts":[[2010,12,3]],"date-time":"2010-12-03T14:29:09Z","timestamp":1291386549000},"page":"1117-1124","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Immunolabeling of the Inhibin-\u03b2A and -\u03b2B Subunit in Normal and Malignant Human Cervical Tissue and Cervical Cancer Cell Lines"],"prefix":"10.1016","volume":"20","author":[{"given":"Julia","family":"J\u00fcckstock","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ansgar","family":"Br\u00fcning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Blankenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Kunze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naim","family":"Shabani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Bergauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Mylonas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/IGC.0b013e3181ef10aa_bb0005","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1016\/S0140-6736(03)13778-6","article-title":"Cervical cancer","volume":"361","author":"Waggoner","year":"2003","journal-title":"Lancet."},{"key":"10.1111\/IGC.0b013e3181ef10aa_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/JOE-08-0549","article-title":"The biology of activin: recent advances in structure, regulation and function","volume":"202","author":"Xia","year":"2009","journal-title":"J Endocrinol."},{"key":"10.1111\/IGC.0b013e3181ef10aa_bb0015","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1210\/edrv.22.6.0450","article-title":"Activins and inhibins in endocrine and other tumors","volume":"22","author":"Risbridger","year":"2001","journal-title":"Endocr Rev."},{"key":"10.1111\/IGC.0b013e3181ef10aa_bb0020","first-page":"97","article-title":"Expression of the inhibin\/activin subunits (-alpha, -betaA and -betaB) in normal and carcinogenic endometrial tissue: possible immunohistochemical differentiation markers","volume":"17","author":"Worbs","year":"2007","journal-title":"Oncol Rep."},{"key":"10.1111\/IGC.0b013e3181ef10aa_bb0025","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.ejca.2009.01.008","article-title":"Inhibin-alpha subunit is an independent prognostic parameter in human endometrial carcinomas: analysis of inhibin\/activin-alpha, -betaA and -betaB subunits in 302 cases","volume":"45","author":"Mylonas","year":"2009","journal-title":"Eur J Cancer."},{"key":"10.1111\/IGC.0b013e3181ef10aa_bb0030","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1172\/JCI17788","article-title":"Antibody blockade of the Cripto CFC domain suppresses tumor cell growth in vivo","volume":"112","author":"Adkins","year":"2003","journal-title":"J Clin Invest."},{"key":"10.1111\/IGC.0b013e3181ef10aa_bb0035","first-page":"2011","article-title":"Expression of HPV, steroid receptors (ERalpha, ERbeta, PR-A and PR-B) and inhibin\/activin subunits (alpha, betaA and betaB) in adenosquamous endometrial carcinoma","volume":"27","author":"Gingelmaier","year":"2007","journal-title":"Anticancer Res."},{"key":"10.1111\/IGC.0b013e3181ef10aa_bb0040","first-page":"1194","article-title":"Expression and secretion of inhibin and activin in normal and neoplastic uterine tissues. High levels of serum activin A in women with endometrial and cervical carcinoma","volume":"83","author":"Petraglia","year":"1998","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1111\/IGC.0b013e3181ef10aa_bb0045","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s10735-009-9246-x","article-title":"Inhibin\/activin-betaE subunit in normal and malignant human cervical tissue and cervical cancer cell lines","volume":"40","author":"Bergauer","year":"2009","journal-title":"J Mol Histol."},{"key":"10.1111\/IGC.0b013e3181ef10aa_bb0050","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ygyno.2003.12.042","article-title":"Expression of the inhibin-alpha subunit in normal, hyperplastic and malignant endometrial tissue: an immunohistochemical analysis","volume":"93","author":"Mylonas","year":"2004","journal-title":"Gynecol Oncol."},{"key":"10.1111\/IGC.0b013e3181ef10aa_bb0055","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1099\/0022-1317-80-7-1725","article-title":"Nucleotide sequences and further characterization of human papillomavirus DNA present in the CaSki, SiHa and HeLa cervical carcinoma cell lines","volume":"80","author":"Meissner","year":"1999","journal-title":"J Gen Virol."},{"key":"10.1111\/IGC.0b013e3181ef10aa_bb0060","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0042-6822(85)90164-3","article-title":"Human papillomavirus types 16 and 18 sequences in carcinoma cell lines of the cervix","volume":"145","author":"Pater","year":"1985","journal-title":"Virology."},{"key":"10.1111\/IGC.0b013e3181ef10aa_bb0065","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s00404-009-1310-y","article-title":"Inhibin\/activin-betaC and -betaE subunits in the Ishikawa human endometrial adenocarcinoma cell line","volume":"282","author":"Kimmich","year":"2010","journal-title":"Arch Gynecol Obstet."},{"key":"10.1111\/IGC.0b013e3181ef10aa_bb0070","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.mce.2004.02.015","article-title":"Re-evaluation of inhibin alpha subunit as a tumour suppressor in prostate cancer","volume":"225","author":"Risbridger","year":"2004","journal-title":"Mol Cell Endocrinol."},{"key":"10.1111\/IGC.0b013e3181ef10aa_bb0075","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1478-811X-7-15","article-title":"Activin signaling as an emerging target for therapeutic interventions","volume":"7","author":"Tsuchida","year":"2009","journal-title":"Cell Commun Signal."},{"key":"10.1111\/IGC.0b013e3181ef10aa_bb0080","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1006\/gyno.2000.5879","article-title":"Endocervical cancer is associated with an increase in the ligands and receptors for transforming growth factor-beta and a contrasting decrease in p27 (Kip1)","volume":"78","author":"Farley","year":"2000","journal-title":"Gynecol Oncol."},{"key":"10.1111\/IGC.0b013e3181ef10aa_bb0085","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.virol.2008.11.046","article-title":"Papillomaviruses in the causation of human cancers\u2014a brief historical account","volume":"384","author":"zur Hausen","year":"2009","journal-title":"Virology."},{"key":"10.1111\/IGC.0b013e3181ef10aa_bb0090","first-page":"75","article-title":"Clinical significance of the expression of activin A in esophageal carcinoma","volume":"22","author":"Yoshinaga","year":"2003","journal-title":"Int J Oncol."},{"key":"10.1111\/IGC.0b013e3181ef10aa_bb0095","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1245\/s10434-007-9631-1","article-title":"Activin a causes cancer cell aggressiveness in esophageal squamous cell carcinoma cells","volume":"15","author":"Yoshinaga","year":"2008","journal-title":"Ann Surg Oncol."},{"key":"10.1111\/IGC.0b013e3181ef10aa_bb0100","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1016\/j.ejca.2010.06.001","article-title":"Inhibin-alpha, -betaA and -betaB subunits in uterine non-endometrioid carcinomas: prognostic significance and clinical implications","volume":"46","author":"Mylonas","year":"2010","journal-title":"Eur J Cancer."}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2FIGC.0b013e3181ef10aa","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24037241?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24037241?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T12:35:10Z","timestamp":1753101310000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24037241"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":20,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["S1048891X24037241"],"URL":"https:\/\/doi.org\/10.1111\/igc.0b013e3181ef10aa","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunolabeling of the Inhibin-\u03b2A and -\u03b2B Subunit in Normal and Malignant Human Cervical Tissue and Cervical Cancer Cell Lines","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/IGC.0b013e3181ef10aa","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 by IGCS and ESGO","name":"copyright","label":"Copyright"}]}}